Individual variability in response is high, with no way to predict who will benefit
Many patients remain on lower maintenance doses (0.250.5 mg weekly) for years without adverse effects, making compounded semaglutide from PlexusDx a practical, sustainable option
Studies also noted better lipid profiles , improved liver enzymes , and lower inflammatory markers , suggesting broad metabolic activity
6 Similarly, as GLP-1RAs significantly reduced the risk of MACE, mortality from CV causes, when compared with placebo, ADA has suggested that these medications should be used in patients with underlying cardiovascular disease
Patients with rheumatoid arthritis considering or currently using GLP-1 medications should engage in comprehensive discussions with their rheumatology team to ensure coordinated, evidence-based care
Because of these effects, GLP-1 is a big focus in type 2 diabetes treatment and weight management research